Journal
FOOD & FUNCTION
Volume 8, Issue 11, Pages 3926-3937Publisher
ROYAL SOC CHEMISTRY
DOI: 10.1039/c7fo00822h
Keywords
-
Funding
- National Natural Science Funding of China [81501869, 81601983, 41506091]
- Medical and Health Science and Technology Project of Zhejiang Province [2016YKA139]
- Zhejiang provincial Public welfare project [2017C33035]
Ask authors/readers for more resources
Osteoarthritis (OA) is a complex process, to which an inflammatory environment contributes markedly. Piceatannol exerts anti-inflammatory effects on several diseases. In the current study, we explored the protective effects of piceatannol on the progression of OA and investigated its molecular target. In vitro, piceatannol not only attenuated the over-production of inflammatory mediators and cytokines-such as nitric oxide (NO), prostaglandin E2 (PGE(2)), tumor necrosis factor alpha (TNF-alpha), and interleukin-6 (IL-6)but also suppressed the expression of cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) at both the mRNA and protein levels. Piceatannol also decreased the expression of metalloproteinase 13 (MMP13) and thrombospondin motifs 5 (ADAMTS5), which mediate extracellular matrix degradation. Mechanistically, we found that piceatannol inhibited IL-1 beta-induced nuclear factor kappa B (NF-kappa B) activation by activating the nuclear factor (erythroid-derived 2)-like 2 (Nrf2)/heme oxygenase 1 (HO-1) pathway. Furthermore, piceatannol exerted protective effects in a mouse model of OA. Taken together, these findings indicate that piceatannol may be a potential therapeutic agent for OA.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available